190 related articles for article (PubMed ID: 20406234)
41. Evidence of focal genetic microheterogeneity in glioblastoma multiforme by area-specific CGH on microdissected tumor cells.
Jung V; Romeike BF; Henn W; Feiden W; Moringlane JR; Zang KD; Urbschat S
J Neuropathol Exp Neurol; 1999 Sep; 58(9):993-9. PubMed ID: 10499441
[TBL] [Abstract][Full Text] [Related]
42. Chromosomal aberrations in primary PDGFRA-mutated gastrointestinal stromal tumors.
Schaefer IM; Delfs C; Cameron S; Gunawan B; Agaimy A; Ghadimi BM; Haller F
Hum Pathol; 2014 Jan; 45(1):85-97. PubMed ID: 24157063
[TBL] [Abstract][Full Text] [Related]
43. A survey of glioblastoma genomic amplifications and deletions.
Rao SK; Edwards J; Joshi AD; Siu IM; Riggins GJ
J Neurooncol; 2010 Jan; 96(2):169-79. PubMed ID: 19609742
[TBL] [Abstract][Full Text] [Related]
44. Genomic analysis reveals secondary glioblastoma after radiotherapy in a subset of recurrent medulloblastomas.
Phi JH; Park AK; Lee S; Choi SA; Baek IP; Kim P; Kim EH; Park HC; Kim BC; Bhak J; Park SH; Lee JY; Wang KC; Kim DS; Shim KW; Kim SH; Kim CY; Kim SK
Acta Neuropathol; 2018 Jun; 135(6):939-953. PubMed ID: 29644394
[TBL] [Abstract][Full Text] [Related]
45. Genetic alteration and expression of the phosphoinositol-3-kinase/Akt pathway genes PIK3CA and PIKE in human glioblastomas.
Knobbe CB; Trampe-Kieslich A; Reifenberger G
Neuropathol Appl Neurobiol; 2005 Oct; 31(5):486-90. PubMed ID: 16150119
[TBL] [Abstract][Full Text] [Related]
46. Comparative genomic hybridization reveals recurrent enhancements on chromosome 20 and in one case combined amplification sites on 15q24q26 and 20p11p12 in glioblastomas.
Brunner C; Jung V; Henn W; Zang KD; Urbschat S
Cancer Genet Cytogenet; 2000 Sep; 121(2):124-7. PubMed ID: 11063794
[TBL] [Abstract][Full Text] [Related]
47. Genetic alterations in primary glioblastomas in Japan.
Fukushima T; Favereaux A; Huang H; Shimizu T; Yonekawa Y; Nakazato Y; Ohagki H
J Neuropathol Exp Neurol; 2006 Jan; 65(1):12-8. PubMed ID: 16410744
[TBL] [Abstract][Full Text] [Related]
48. Clinical implementation of integrated whole-genome copy number and mutation profiling for glioblastoma.
Ramkissoon SH; Bi WL; Schumacher SE; Ramkissoon LA; Haidar S; Knoff D; Dubuc A; Brown L; Burns M; Cryan JB; Abedalthagafi M; Kang YJ; Schultz N; Reardon DA; Lee EQ; Rinne ML; Norden AD; Nayak L; Ruland S; Doherty LM; LaFrankie DC; Horvath M; Aizer AA; Russo A; Arvold ND; Claus EB; Al-Mefty O; Johnson MD; Golby AJ; Dunn IF; Chiocca EA; Trippa L; Santagata S; Folkerth RD; Kantoff P; Rollins BJ; Lindeman NI; Wen PY; Ligon AH; Beroukhim R; Alexander BM; Ligon KL
Neuro Oncol; 2015 Oct; 17(10):1344-55. PubMed ID: 25754088
[TBL] [Abstract][Full Text] [Related]
49. WHO grade-specific comparative genomic hybridization pattern of astrocytoma - a meta-analysis.
Holland H; Koschny T; Ahnert P; Meixensberger J; Koschny R
Pathol Res Pract; 2010 Oct; 206(10):663-8. PubMed ID: 20570053
[TBL] [Abstract][Full Text] [Related]
50. PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas.
Tohma Y; Gratas C; Biernat W; Peraud A; Fukuda M; Yonekawa Y; Kleihues P; Ohgaki H
J Neuropathol Exp Neurol; 1998 Jul; 57(7):684-9. PubMed ID: 9690672
[TBL] [Abstract][Full Text] [Related]
51. p53 mutation and epidermal growth factor receptor overexpression in glioblastoma.
Yoon KS; Lee MC; Kang SS; Kim JH; Jung S; Kim YJ; Lee JH; Ahn KY; Lee JS; Cheon JY
J Korean Med Sci; 2001 Aug; 16(4):481-8. PubMed ID: 11511795
[TBL] [Abstract][Full Text] [Related]
52. Molecular classification of human gliomas using matrix-based comparative genomic hybridization.
Roerig P; Nessling M; Radlwimmer B; Joos S; Wrobel G; Schwaenen C; Reifenberger G; Lichter P
Int J Cancer; 2005 Oct; 117(1):95-103. PubMed ID: 15880582
[TBL] [Abstract][Full Text] [Related]
53. Amplification and overexpression of MDM2 in primary (de novo) glioblastomas.
Biernat W; Kleihues P; Yonekawa Y; Ohgaki H
J Neuropathol Exp Neurol; 1997 Feb; 56(2):180-5. PubMed ID: 9034372
[TBL] [Abstract][Full Text] [Related]
54. Specific chromosomal imbalances as detected by array CGH in ependymomas in association with tumor location, histological subtype and grade.
Rousseau A; Idbaih A; Ducray F; Crinière E; Fèvre-Montange M; Jouvet A; Delattre JY
J Neurooncol; 2010 May; 97(3):353-64. PubMed ID: 19865800
[TBL] [Abstract][Full Text] [Related]
55. Genomic aberrations in 80 cases of primary glioblastoma multiforme: Pathogenetic heterogeneity and putative cytogenetic pathways.
Dahlback HS; Brandal P; Meling TR; Gorunova L; Scheie D; Heim S
Genes Chromosomes Cancer; 2009 Oct; 48(10):908-24. PubMed ID: 19603525
[TBL] [Abstract][Full Text] [Related]
56. [Detection of chromosomal imbalance in ependymoma by comparative genomic hybridization].
Wu WX; Yu SZ; Sun CY; Wang Q; Jin SM; An TL
Zhonghua Bing Li Xue Za Zhi; 2009 Mar; 38(3):148-52. PubMed ID: 19575847
[TBL] [Abstract][Full Text] [Related]
57. Array CGH in brain tumors.
Mohapatra G; Sharma J; Yip S
Methods Mol Biol; 2013; 973():325-38. PubMed ID: 23412799
[TBL] [Abstract][Full Text] [Related]
58. Chromosome copy number changes carry prognostic information independent of KIT/PDGFRA point mutations in gastrointestinal stromal tumors.
Silva M; Veiga I; Ribeiro FR; Vieira J; Pinto C; Pinheiro M; Mesquita B; Santos C; Soares M; Dinis J; Santos L; Lopes P; Afonso M; Lopes C; Teixeira MR
BMC Med; 2010 May; 8():26. PubMed ID: 20470368
[TBL] [Abstract][Full Text] [Related]
59. Genetic pathways to glioblastomas.
Ohgaki H
Neuropathology; 2005 Mar; 25(1):1-7. PubMed ID: 15822813
[TBL] [Abstract][Full Text] [Related]
60. Detection of genetic alterations in gastric cancer patients from Saudi Arabia using comparative genomic hybridization (CGH).
Bibi F; Ali I; Naseer MI; Ali Mohamoud HS; Yasir M; Alvi SA; Jiman-Fatani AA; Sawan A; Azhar EI
PLoS One; 2018; 13(9):e0202576. PubMed ID: 30212456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
